← FDA DRUG APPROVALS
FDA ANDA · ANDA212348
POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE
dextrose monohydrate, sodium chloride, and potassium chloride
Sponsor: FRESENIUS KABI USA
APPLICATION
ANDA212348
TYPE
ANDA
ORIGINAL APPROVAL
2021-07-30
LATEST ACTION
2021-07-30
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERPrescription
DEXTROSE 5GM/100ML, POTASSIUM CHLORIDE 149MG/100ML, SODIUM CHLORIDE 225MG/100ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERPrescription
DEXTROSE 5GM/100ML, POTASSIUM CHLORIDE 149MG/100ML, SODIUM CHLORIDE 225MG/100ML · INJECTABLE · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.